About Us

Bayer Schering Pharma is a research-based pharmaceutical and biotechnology company whose . activities are focused on six business areas: diagnostics imaging, haematology/cardiology, oncology, primary care, specialized therapeutics, and women’s health.

Using interdisciplinary networks it builds bridges to academic researchers around the world, as well as to highly specialized biotechnology pioneers and partners in the pharmaceutical industry. Bayer Schering Pharma also combines its own long-standing medical and pharmaceutical expertise with the latest discoveries from genomic research. Throughout, its research focuses on a meaningful combination of early diagnosis, prevention, treatment and therapy control.
This site is provided by Bayer Schering Pharma AG, Germany, represented by the Executive Board:

Arthur Higgins (Chairman)
Werner Baumann
Andreas Busch
Ulrich Koestlin
Kemal Malik
Gunnar Reimann

Postal address:
Bayer Schering Pharma AG
13342 Berlin
Germany

Trade register: county court Charlottenburg Berlin 93 HRB 283
Registration number: DE 136.563.568


Contact: sebastian.schwerdt@bayerhealthcare.de